Association of serum B-cell activating factor level and proportion of memory and transitional B cells with clinical response after rituximab treatment of bullous pemphigoid patients.

Autor: Hall RP 3rd; Department of Dermatology, Duke University School of Medicine, Durham, North Carolina, USA; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA. Electronic address: Russell.Hall@duke.edu., Streilein RD; Department of Dermatology, Duke University School of Medicine, Durham, North Carolina, USA; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Hannah DL; Department of Dermatology, Duke University School of Medicine, Durham, North Carolina, USA; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., McNair PD; Department of Dermatology, Duke University School of Medicine, Durham, North Carolina, USA; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Fairley JA; Department of Dermatology, University of Iowa School of Medicine, Iowa City, Iowa, USA., Ronaghy A; Department of Dermatology, Duke University School of Medicine, Durham, North Carolina, USA; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Edhegard KD; Department of Dermatology, Duke University School of Medicine, Durham, North Carolina, USA; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA., Levesque MC; Department of Dermatology, Duke University School of Medicine, Durham, North Carolina, USA; Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.
Jazyk: angličtina
Zdroj: The Journal of investigative dermatology [J Invest Dermatol] 2013 Dec; Vol. 133 (12), pp. 2786-2788. Date of Electronic Publication: 2013 Jun 03.
DOI: 10.1038/jid.2013.236
Databáze: MEDLINE